Each year, we release Request for Applications or Letter of Intent (LOI) Announcements to communicate which grant mechanisms and scientific focus areas are available for funding. The types of mechanisms and the scientific focus areas may vary from year to year.
This year, we’re offering three grant funding mechanisms for which early career breast cancer researchers anywhere in the world are invited to apply. These three Komen Training and Career Development awards seek to bridge the funding gap faced by recently graduated Ph.D.s and early faculty as they start their careers in breast cancer research. Grants funded by Komen provide the preparation necessary to compete for independent funding as an established and successful breast cancer researcher.
LOI Announcement Release Date: May 18, 2016Application system open date: May 18, 2016LOI Submission deadline July 14, 2016
$450,000 combined direct and indirect costs; ($150,000 per year for up to 3 years)
CCR Grants provide unique opportunities for scientists who have held faculty positions for no more than five years at the time of Application to achieve research independence. CCR grants provide support for hypothesis-driven research projects that have significant potential to advance our understanding of breast cancer, lead to reductions in breast cancer incidence and/or mortality, and move us toward the goal of a world without breast cancer. There are two research focus areas: Basic/Translational and Clinical.There are two
research focus areas: Basic/Translational and Clinical.
This award mechanism provides support for junior faculty proposing research projects that are laboratory- or field- based and do not meet Komen's definition of clinical research. Studies focusing on quality of life or survivorship issues are not appropriate for this mechanism.
This award mechanism provides support for junior faculty for patient-oriented research projects that involve direct interactions with human subjects/patients. This includes studies such as therapeutic interventions or clinical trials.
Komen defines clinical research as hypothesis driven, patient-oriented research for which an investigator directly interacts with human subjects/patients, in conjunction with laboratory-based research, as appropriate. This includes studies such as therapeutic interventions or clinical trials.
Download the current Career Catalyst Research Grants LOI Announcement (PDF)
$180,000 direct costs only; ($60,000 per year for 2 to 3 years)PDF Grants are intended to attract and preserve today’s young scientists and clinicians who will fuel the future and become the next generation of leaders in the field of breast cancer research. These leaders will play key roles in reducing breast cancer incidence and mortality within the next decade, with the ultimate goal of ending breast cancer forever.
There are 2 Research Focus Areas:
Basic/Translational and Clinical
This grant mechanism provides support for research projects that are laboratory- or field- based and do not meet Komen's definition of clinical research. Studies focusing on quality of life or survivorship issues are not appropriate for this mechanism.
This grant mechanism provides support for fellows proposing clinical, patient-oriented research projects that involve direct interactions with human subjects/patients. This includes studies such as therapeutic interventions or clinical trials.Komen defines clinical research a hypothesis driven, patient-oriented research for which an investigator directly interacts with human subjects/patients, in conjunction with laboratory-based research as appropriate. This includes studies such as therapeutic interventions or clinical trials.Download the current Postdoctoral Fellowship Grants LOI Announcement (PDF)
Up to $135,000 per year, direct costs only, for up to 3
GTDR Grants are intended to establish and/or to sustain
a training program for a minimum of three graduate students who are seeking
careers dedicated to understanding and eliminating disparities in breast cancer
outcomes across population groups.
GTDR Grants will only be a one step process for FY17 and will not require a Letter of Intent. The Request for Applications (RFA) will be released later this summer.
Download the current Graduate Training in Disparities Research Announcement (PDF)
Susan G. Komen® utilizes a multi-step approach to grant application and review that first requires submission of a Letter of Intent and upon invitation only, to those individuals whose Letter of Intent have been deemed highly meritorious, an Application. It is anticipated that Applications will be invited from approximately 20-25% of Letter of Intent submissions.
The Letter of Intent is first administratively reviewed for eligibility, compliance with submission guidelines and responsiveness to the research focus specified in this announcement. Each Letter of Intent that does not meet eligibility, submission, or responsiveness requirements will be administratively withdrawn and WILL NOT undergo scientific review.
Each qualified Letter of Intent is reviewed by a panel of three scientists with appropriate expertise and a patient advocate. Scientist and advocate reviewers assess the strengths and weaknesses of each application based on defined review criteria contained within this Announcement.
Applicants/PIs will be notified of Letter of Intent review decisions via email, and be granted access to reviewer comments. Applicants/PIs invited to submit an Application will then be granted access to the Application site.
All institutions and industry
partners must agree to adhere to Komen's Policies and Procedures for Research and Training Grants.
View current funding opportunities for Scientific Research Grants.
View currently funded Scientific Research Grants.
See how Komen researchers are making difference.
See what types of clinical trials Komen research has supported.
Learn how breast cancer survivors and advocates are involved in our scientific research.
Submit a pre-application
Need help? Contact the Komen Grants Help Desk.